Author: staff

Stocks to Trade

Why Galera Therapeutics (GRTX) Stock Is Surging Today?

Galera Therapeutics, Inc. (NASDAQ: GRTX) is experiencing a notable surge in its stock price today, with a 4.32% increase, reaching $3.14 during early trading. In the previous session, Galera Therapeutics’ shares concluded at $3.01. The rise in GRTX stock is attributed to receiving regulatory approval.

Equities Feed

Why Did SCWorx (WORX) Stock Rise In Extended Trades?

SCWorx Corp. (Nasdaq: WORX) has seen its stock price rise by 5.00% to $0.4622 in Tuesday’s after-hours trading session. The increase in stock price was due to the company’s recent success in winning a new healthcare customer. This is a positive development for the company

NNOX Stock
Market Summary

Why Did Fusion Fuel (HTOO) Stock Gain Traction After-Hours?

On Friday, Fusion Fuel Green PLC (NASD: HTOO) had been moving up in the after-hours trading market with its share prices seeing a noticeable increase of 3.05%. At last check, the shares were trading at $4.05, which is a result of the company entering into

Trending News

What Motivated Vyant Bio (VYNT) Stock To Climb 116%?

After learning that the biotechnology business is looking at strategic options, shares of Vyant Bio Inc. (Nasdaq: VYNT) were up 116.94% at $1.67 at the time of our last check in pre-market trading. What action did VYNT take? LifeSci Capital has been hired by Vyant

Market Summary

How Did The SCYNEXIS (SCYX) Stock Surge In The Extended Session, Jumping 12%?

After receiving a research grant, SCYNEXIS Inc. (NASD: SCYX) has increased 12.50% to $1.80 in after-hours trading on the latest check Thursday. How much funding has SCYX received? Researchers at Case Western Reserve University in Cleveland have received a competitive research grant from the National

Equities Feed

SenesTech (SNES) Stock Rose 8% After-Hours. How Did That Happen?

Shares of SenesTech Inc. (Nasdaq: SNES) were trading 8.33% higher at $2.86 as of the most recent check in after-hours trading. Following the news of a substantial deployment by the specialists in rodent fertility control and creators of ContraPest, the only rat contraceptive approved by